Model
Edge
Pernix Therapeutics Holdings, Inc.
0001024126
Filing Type
10-K
Filing Date
3/7/2018
Updated
3/8/18, 9:23 AM
Filing
10-K
Earnings Release
Exhibits
10-K
10-K
EX-3.2
BYLAWS
EX-10.41
OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDINGS, INC. AND DOUGLAS J. SWIRSKY
EX-10.42
OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDINGS, INC. AND JOHN R. LEONE
EX-10.43
WAIVER, AMENDMENT AND CONSENT AGREEMENT, DATED NOVEMBER 2, 2017, AMONG PERNIX THERAPEUTICS HOLDINGS, INC. AND THE OTHER SIGNATORIES THERETO
EX-21.1
SUBSIDIARIES
EX-23.1
CONSENT
EX-31.1
CEO 302 CERTIFICATE
EX-31.2
CFO 302 CERTIFICATE
EX-32.1
906 CERTIFICATE
GRAPHIC
LOGO
EX-101.INS
XBRL INSTANCE DOCUMENT